Lilly Cymbalta Launched At Premium Price; Once-Daily Dose Encouraged
Executive Summary
Lilly's antidepressant Cymbalta is priced at a 73% premium to Wyeth's Effexor XR
You may also be interested in...
Yentreve Goes Back To Drawing Board After Lilly/BI Withdraw NDA
Lilly and Boehringer Ingelheim's decision to withdraw the Yentreve application based upon FDA's expected negative review decision will give the companies additional time to develop a marketing strategy
Yentreve Goes Back To Drawing Board After Lilly/BI Withdraw NDA
Lilly and Boehringer Ingelheim's decision to withdraw the Yentreve application based upon FDA's expected negative review decision will give the companies additional time to develop a marketing strategy
Antidepressant “Black Box” Presents Barrier To DTC Advertising
FDA's proposed "black box" warning for all antidepressants would likely mean an end to television ads for the products